Does SYNTAX score II predict poor myocardial perfusion in ST-segment elevation myocardial infarction?

Cardiology Journal

Volumn 23, Issue 3, 2016, Pages 317-323

  Wang, Gang ^a   Hua, Q ^a   Li, Jing ^a   Zhu, Weiwei ^a   Luo, Hongyu ^a   Zhang, Yuhui ^b   Wang, Chen ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CANGZHOU CENTRAL HOSPITAL   (China)

Author keywords

Myocardial blush grade; Myocardial perfusion; Primary percutaneous coronary intervention; ST segment elevation myocardial infarction; SYNTAX score II

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TIROFIBAN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY STENTING; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEART MUSCLE PERFUSION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL BLUSH GRADE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYNTAX SCORE; THROMBECTOMY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BLOOD FLOW; ELECTROCARDIOGRAPHY; FOLLOW UP; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; ST ELEVATION MYOCARDIAL INFARCTION;

AGED; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; ST ELEVATION MYOCARDIAL INFARCTION;

EID: 84978091673     PISSN: 18975593     EISSN: 1898018X     Source Type: Journal    
DOI: 10.5603/CJ.a2016.0006     Document Type: Article

References (28)

1. Steg PG, James SK, Atar D et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J, 2012; 33: 2569–2619.
2. Roe MT, Ohman EM, Maas AC et al. Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. J Am Coll Cardiol, 2001; 37: 9–18.
3. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol, 2009; 54: 281–292.
4. van’t Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation, 1998; 97: 2302–2306.
5. Haager PK, Christott P, Heussen N, Lepper W, Hanrath P, Hoffmann R. Prediction of clinical outcome after mechanical revascularization in acute myocardial infarction by markers of myocardial reperfusion. J Am Coll Cardiol, 2003; 41: 532–538.
6. Henriques JP, Zijlstra F, van’t Hof AW et al. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation, 2003; 107: 2115–2119.
7. Poli A, Fetiveau R, Vandoni P et al. Integrated analysis of myocardial blush and ST-segment elevation recovery after successful primary angioplasty: Real-time grading of microvascular reperfusion and prediction of early and late recovery of left ventricular function. Circulation, 2002; 106: 313–318.
8. Maioli M, Zeymer U, van’t Hof AW et al. Impact of preprocedural TIMI flow on myocardial perfusion, distal embolization and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb/ /IIIa inhibitors. J Invasive Cardiol, 2012; 24: 324–327.
9. Pasha K, Ali MA, Habib MA, Debnath RC, Islam MN. In-hospital outcome of patients with acute STEMI with impaired renal function. Mymensingh Med J, 2011; 20: 425–430.
10. Marechaux S, Barrailler S, Pincon C et al. Prognostic value of hemoglobin decline over the GRACE score in patients hospitalized for an acute coronary syndrome. Heart Vessels, 2012; 27: 119–127.
11. Farooq V, van Klaveren D, Steyerberg EW et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary in tervention for individual patients: Development and validation of SYNTAX score II. Lancet, 2013; 381: 639–650.
12. Farooq V, van Klaveren D, Steyerberg EW, Serruys PW. SYNTAX score II: Authors’ reply. Lancet, 2013; 381: 1899–1900.
13. Gibson CM, de Lemos JA, Murphy SA et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: A TIMI 14 substudy. Circulation, 2001; 103: 2550–2554.
14. Sianos G, Morel MA, Kappetein AP et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroInterventio, 2005; 1: 219–227.
15. Garg S, Sarno G, Serruys PW et al. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. J Am Coll Cardiol Cardiovasc Interv, 2011; 4: 66–75.
16. Magro M, Nauta S, Simsek C et al. Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAX--score study. Am Heart J, 2011; 161: 771–781.
17. Serruys PW, Morice MC, Kappetein AP et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 2009; 360: 961–972.
18. Tarantini G, Ramondo A, Napodano M et al. Myocardial perfusion grade and survival after percutaneous transluminal coronary angioplasty in patients with cardiogenic shock. Am J Cardiol, 2004; 93: 1081–1085.
19. Brener SJ, Dizon JM, Mehran R et al. Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: Analysis from the HORIZONS-AMI trial. Am Heart J, 2013; 166: 676–683.
20. Tsvetkov H, Mosseri M. Myocardial blush grade: an interventional method for assessing myocardial perfusion. Isr Med Assoc J, 2008; 10: 465–467.
21. Meller SM, Lansky AJ, Costa RA et al. Implications of myocardial reperfusion on survival in women versus men with acute myocardial infarction undergoing primary coronary intervention. Am J Cardiol, 2013; 112: 1087–1092.
22. Fearon WF, Shah M, Ng M et al. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol, 2008; 51: 560–565.
23. Reilly MP, Delanty N, Roy L et al. Increased formation of the iso-prostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: Evidence for oxidant stress during coronary reperfusion in humans. Circulation, 1997; 96: 3314–3320.
24. Hempel SL, Wessels DA, Spector AA. Effect of glutathione on endothelial prostacyclin synthesis after anoxia. Am J Physiol, 1993; 264: C1448–C1457.
25. Demirbag R, Yilmaz R, Gur M et al. Lymphocyte DNA damage in patients with acute coronary syndrome and its relationship with severity of acute coronary syndrome. Mutat Res, 2005; 578: 298–307.
26. Cohen DJ, Doucet M, Cutlip DE, Ho KK, Popma JJ,Kuntz RE. Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: Another smoker’s paradox? Circulation, 2001; 104: 773–778.
27. Andrikopoulos GK, Richter DJ, Dilaveris PE et al. In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the “smoker’s paradox” in a countrywide study. Eur Heart J, 2001; 22: 776–784.
28. Campos CM, Garcia-Garcia HM, van Klaveren D et al. Validity of SYNTAX score II for risk stratification of percutaneous coronary interventions: A patient-level pooled analysis of 5433 patients enrolled in contemporary coronary stent trials. Int J Cardiol, 2015; 187: 111–115.